ApprovalTrail

Drug · DIN 02503433

PANCREASE MT 2

Yes: authorized and sold in Canada

Authorized, and the company reports that it sells it in Canada.

Status Marketed since December 21, 2020; first marketed December 21, 2020.
Drug Identification Number (DIN)
02503433
Company (DIN owner)
Vivus Llc.Campbell, California, United States
Schedule
Schedule d; Prescription
Dosage form
Capsule (Delayed-Release)
Route
Oral
Therapeutic class (ATC)
Multienzymes (lipase, protease etc) A09AA02
Class
Human
Record last updated
June 5, 2025

Active ingredients

As listed in the Drug Product Database.

IngredientStrengthPer
LIPASE2600 UNIT
AMYLASE10850 UNIT
PROTEASE6200 UNIT